Clinical Trial Update: A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of Adze1.C in participants with metastatic melanoma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Adze1.C

Snippet

Sponsor: Adze Biotechnology Australia Pty Ltd | Conditions: Metastatic Melanoma | Phase 1 | Status: RECRUITING